INS and Hyperglycemia: Impaired insulin secretion by pancreatic β-cells is a core pathomechanism of T2DM, where disease progression hampers insulin secretion’s ability to maintain glucose homeostasis, leading to hyperglycemia (Weyer et al., 1999; DeFronzo et al., 2015).